Performance of cardiovascular risk factors for predicting truncation
Variable | Sensitivity | Specificity | AUC | 95% CI | ||||
---|---|---|---|---|---|---|---|---|
No. | % | 95% CI | No. | % | 95% CI | |||
Agea | 10/15 | 67% | 38%–88% | 82/138 | 59% | 51%–68% | 0.63 | 0.47–0.78 |
rLVEF | 7/15 | 47% | 21%–73% | 121/138 | 88% | 81%– 93% | 0.67 | 0.54– 0.81 |
Atrial fibrillation | 10/15 | 67% | 38%–88% | 83/138 | 60% | 51%–68% | 0.63 | 0.50– 0.76 |
Absence of hypertension | 8/15 | 53% | 27%–79% | 96/138 | 70% | 61%–77% | 0.61 | 0.48– 0.75 |
Diabetes mellitus | 5/15 | 33% | 12%–62% | 93/138 | 67% | 59%–75% | 0.50 | 0.37– 0.63 |
Absence of hyperlipidemia | 9/15 | 60% | 32%–84% | 65/138 | 47% | 39%–56% | 0.54 | 0.40– 0.67 |
Multivariable model (age, rLVEF, hypertension)b | 11/15 | 73% | 45%–92% | 108/138 | 78% | 70%–85% | 0.75 | 0.60– 0.90 |